Blood Institute Led News Today : Breaking News, Live Updates & Top Stories | Vimarsana

UC group launches clinical trial using CRISPR to correct sickle cell disease gene defect
April 1, 2021UCLA
Scientists at UCLA, UC San Francisco and UC Berkeley have received U.S. Food and Drug Administration approval to jointly launch an early phase, first-in-human clinical trial of a CRISPR gene correction therapy in patients with sickle cell disease using the patients’ own blood-forming stem cells.
The trial will combine CRISPR technology developed at the Innovative Genomics Institute a UC Berkeley–UCSF initiative founded by Berkeley’s Nobel Prize–winning scientist Jennifer Doudna with UCLA’s expertise in genetic analysis and cell manufacturing, and the decades-long expertise at UCSF Benioff Children’s Hospital Oakland in cord blood and marrow transplantation and in gene therapy for sickle cell disease. The four-year study will include six adults and three adolescents with severe sickle cell disease. It is planned to begin this summer in Oakland and L ....

United States , Donald Kohn , Mark Walters , Fyodor Urnov , Los Angeles , Jennifer Doudna , California Institute For Regenerative Medicine , Broad Stem Cell Research Center , David Geffen School Of Medicine , Drug Administration , Cure Sickle Cell Initiative , Marrow Transplant Program , Innovative Genomics Institute , Doris Duke Charitable Foundation , National Heart , Nobel Prize , Hospital Oakland , Jordan Family Director , David Geffen School , Stem Cell Research , California Institute , Regenerative Medicine , Blood Institute Led , Doris Duke Charitable , ஒன்றுபட்டது மாநிலங்களில் , டொனால்ட் கோன் ,